EMA — authorised 24 February 2009
- Marketing authorisation holder: DAIICHI SANKYO EUROPE GMBH
- Status: approved
EMA authorised Effient on 24 February 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 24 February 2009.
DAIICHI SANKYO EUROPE GMBH holds the EU marketing authorisation.